logo

For the Inventor, By the Inventor

Lagarrigue, France

Serge Halazy

This inventor holds 12 USPTO granted patents, plus 3 CIPO patents. Top assignees: Pierre Fabre Medicament, Merrell Pharmaceuticals, Inc.. Active years: 1996-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Serge Halazy. Retrieved from https://idiyas.com/inventor/serge-halazy-by11mp2m

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12

% Patents Active = 91.7

 

Average Co-Inventor Count = 2.5

ph-index = 7

Forward Citations = 180(Granted Patents)


Location History:

  • Wolfisheim, FR (1996)
  • Lagarrigue, FR (1997 - 2003)

Company Filing History:

goldMedal7 out of 269 
 
Pierre Fabre Medicament
 patents
silverMedal5 out of 194 
 
Merrell Pharmaceuticals, Inc.
 patents

Years Active: 1996-2003

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents
1. 6589953 - Indole derivatives as 5-HT1B and 5-HT1D agonists (2003-07-08),
2. 6277853 - Indole derivatives as 5-HT1B and 5-HT1D agonists (2001-08-21),
3. 6110917 - Methanesulphonate salt of an arylpiperazine derived from tryptamine and (2000-08-29),
4. 5922696 - Ethylenic and allenic phosphonate derivatives of purines (1999-07-13),
5. 5852049 - Aromatic ethers derived from indoles which are useful as medicaments (1998-12-22),
6. 5817647 - Unsaturated acetylene phosphonate derivatives of purines (1998-10-06),
7. 5789412 - Piperazides derived from arylpiperazine, processes for their (1998-08-04),
8. 5726177 - Indole-derived arylpiperazines as ligands for 5HT.sub.1 -like, (1998-03-10),
9. 5641779 - Selective ligands of 5-HT.sub.1D -5-HT.sub.1B receptors derived from (1997-06-24),
10. 5538978 - 9-purinyl phosphonic acid derivatives (1996-07-23),
11. 5527803 - 9-purinyl phosphonic acid derivatives (1996-06-18),
12. 5494912 - 9-purinyl phosphonic acid derivitives for treating gout (1996-02-27),

Title: The Innovative Contributions of Serge Halazy

Introduction

Serge Halazy is a notable inventor based in Lagarrigue, France. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel therapeutic compounds. With a total of 12 patents to his name, Halazy's work has had a considerable impact on the treatment of various diseases.

Latest Patents

One of Halazy's latest patents focuses on indole derivatives as 5-HT1B and 5-HT1D agonists. This invention concerns novel indole piperazine derivatives of formula (I). It also details a method for preparing these compounds and their use as therapeutically active substances, particularly for treating or preventing diseases related to the dysfunction of 5-HT receptors.

Career Highlights

Throughout his career, Halazy has worked with prominent companies in the pharmaceutical industry, including Pierre Fabre Medicament and Merrell Pharmaceuticals, Inc. His expertise in medicinal chemistry has allowed him to contribute to the development of innovative treatments that address critical health issues.

Collaborations

Halazy has collaborated with esteemed colleagues in his field, including Michel Perez and Peter Pauwels. These partnerships have further enhanced his research and development efforts, leading to groundbreaking advancements in therapeutic compounds.

Conclusion

Serge Halazy's contributions to medicinal chemistry and his innovative patents demonstrate his commitment to improving healthcare through scientific research. His work continues to influence the development of new treatments for various diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…